• Kaoutar Ouazzani Touhami, Hind El Bayed Sakkali, Fakhreddine Maaloum, Idrissa Diawara, Makine Ouazzani Touhami, Mohamed Bezzari, Khalid Zerouali, and Houria Belabbes.
• Laboratoire de Bactériologie, Virologie et Hygiène Hospitalière, Centre Hospitalier Universitaire Ibn Rochd, Casablanca, Maroc.
• Pan Afr Med J. 2019 Jan 1; 32: 203.

AbstractPneumococcal meningitis is a global scourge. It is a major cause of morbidity and mortality. In Morocco, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the National Immunization Program in October 2010 according to the immunization schedule 2 + 1 and replaced by PCV10 in July 2012, according to the same schedule. Despite the use of the PCV13, which is essential in the fight against pneumococcal disease, the emergence of new non-vaccine serotypes always results in meningitis in children, causing serious sequelae. We report the case of an infant vaccinated with two doses of PCV13 with meningitis caused by Streptococcus pneumoniae serotype 7a. The peculiarity of this case study lies in pneumococcal meningitis due to Streptococcus pneumoniae serotype 7a not included in the PCV13 in an infant immunized by 2 doses of PCV13. We here insist on the need and the importance of an observatory for pneumococcal meningitis and of a wide epidemiological study in order to determine the serotypes in Morocco after the introduction of PCV13 and then of PCV10.

19 keywords...

hide…